Wave Life Sciences Pte Ltd.
We are a preclinical biopharmaceutical company with an innovative and proprietary synthetic chemistry drug development platform that we are using to design, develop and commercialize a broad pipeline of first-in-class or best-in-class nucleic acid therapeutic candidates. Nucleic acid therapeutics have the potential to address diseases that have been difficult to treat with small molecule drugs or biologics and have emerged as a large and promising class of drugs. We are initially developing nucleic acid therapeutics that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins.
|Address||8 Cross Street #10-00, PWC Building, Singapore 048424|
|Phone Number||+65 6236 7389|
|View Prospectus:||Wave Life Sciences Pte Ltd.|
|Revenues||$0.0 mil (last 12 months)|
|Net Income||$-10.3 mil (last 12 months)|
|Price range||$16.00 - $16.00|
|Est. $ Volume||$102.0 mil|
|Manager / Joint Managers||Jefferies/ Leerink Partners|
|CO-Managers||JMP Securities/ SunTrust Robinson Humphrey|
|Expected To Trade:||11/11/2015|
|Quiet Period Expiration Date:||Available only to Subscribers|
|Lock-Up Period Expiration Date:||Available only to Subscribers|
|SCOOP Rating||Available only to Subscribers|
|Rating Change||Available only to Subscribers|